Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.

Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.
复制标题

DOI:
10.1371/journal.pone.0023741
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Mohany M
Mohany M
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Badr G;Lefevre EA;Mohany M

文献摘要

参考文献

被引文献

相似文献

In multiple myeloma (MM), malignant plasma cells reside in the bone marrow, where they accumulate in close contact with stromal cells. The mechanisms responsible for the chemotaxis of malignant plasma cells are still poorly understood. Thus, we investigated the mechanisms involved in the chemotaxis of MDN and XG2 MM cell lines. Both cell lines strongly expressed CCR9, CXCR3 and CXCR4 chemokine receptors but only migrated toward CXCL12. Activation of CXCR4 by CXCL12 resulted in the association of CXCR4 with CD45 and activation of PLCβ3, AKT, RhoA, IκBα and ERK1/2. Using siRNA-silencing techniques, we showed CD45/CXCR4 association is essential for CXCL12-induced migration of MM cells. Thymoquinone (TQ), the major active component of the medicinal herb Nigella sativa Linn, has been described as a chemopreventive and chemotherapeutic compound. TQ treatment strongly inhibited CXCL12-mediated chemotaxis in MM cell lines as well as primary cells isolated from MM patients, but not normal PBMCs. Moreover, TQ significantly down-regulated CXCR4 expression and CXCL12-mediated CXCR4/CD45 association in MM cells. Finally, TQ also induced the relocalization of cytoplasmic Fas/CD95 to the membrane of MM cells and increased CD95-mediated apoptosis by 80%. In conclusion, we demonstrate the potent anti-myeloma activity of TQ, providing a rationale for further clinical evaluation.
DOI: 10.1006/bbrc.2001.6215
发表时间: 2002-01-11
影响因子: 3.1
作者:
Augstein, P;Dunger, A;Salzsieder, E
通讯作者: Salzsieder, E
DOI: 10.1016/j.cancergencyto.2006.01.002
发表时间: 2006-06-01
影响因子: --
作者:
Ishii, Yuko;Hsiao, Hui-Hua;Ohyashiki, Kazuma
通讯作者: Ohyashiki, Kazuma
DOI: 10.1194/jlr.m700389-jlr200
发表时间: 2008-10
影响因子: 6.5
作者:
Jakobsen CH;Størvold GL;Bremseth H;Follestad T;Sand K;Mack M;Olsen KS;Lundemo AG;Iversen JG;Krokan HE;Schønberg SA
通讯作者: Schønberg SA
DOI: 10.1182/blood-2006-07-035857
发表时间: 2007-04-01
期刊: BLOOD
影响因子: 20.3
作者:
Alsayed, Yazan;Ngo, Hai;Ghobrial, Irene M.
通讯作者: Ghobrial, Irene M.
DOI: 10.1074/jbc.m211803200
发表时间: 2003-03-14
影响因子: 4.8
作者:
Fernandis, AZ;Cherla, RP;Ganju, RK
通讯作者: Ganju, RK